MX2017000154A - Sistema de rinovacunacion de la vacuna contra la influenza. - Google Patents

Sistema de rinovacunacion de la vacuna contra la influenza.

Info

Publication number
MX2017000154A
MX2017000154A MX2017000154A MX2017000154A MX2017000154A MX 2017000154 A MX2017000154 A MX 2017000154A MX 2017000154 A MX2017000154 A MX 2017000154A MX 2017000154 A MX2017000154 A MX 2017000154A MX 2017000154 A MX2017000154 A MX 2017000154A
Authority
MX
Mexico
Prior art keywords
influenza vaccine
vaccination system
nasal vaccination
vaccine nasal
influenza
Prior art date
Application number
MX2017000154A
Other languages
English (en)
Inventor
Taizou Kamishita
Takashi Miyazaki
Original Assignee
Toko Yakuhin Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toko Yakuhin Kogyo Kk filed Critical Toko Yakuhin Kogyo Kk
Publication of MX2017000154A publication Critical patent/MX2017000154A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/006—Sprayers or atomisers specially adapted for therapeutic purposes operated by applying mechanical pressure to the liquid to be sprayed or atomised
    • A61M11/007—Syringe-type or piston-type sprayers or atomisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/001—Particle size control
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M11/00—Sprayers or atomisers specially adapted for therapeutic purposes
    • A61M11/06—Sprayers or atomisers specially adapted for therapeutic purposes of the injector type
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2206/00—Characteristics of a physical parameter; associated device therefor
    • A61M2206/10—Flow characteristics
    • A61M2206/16—Rotating swirling helical flow, e.g. by tangential inflows
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0618—Nose
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pulmonology (AREA)
  • Mycology (AREA)
  • Mechanical Engineering (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

La presente invención se refiere a un sistema de rinovacunación contra la influenza, que comprende una jeringa médica llena con una composición de vacuna de influenza que comprende un virión de influenza entero inactivado y un material de base de gel que comprende polímero carboxivinilo para administrar la composición de vacuna de influenza a mucosa nasal, que se caracteriza por no comprender un adyuvante.
MX2017000154A 2014-06-25 2015-06-24 Sistema de rinovacunacion de la vacuna contra la influenza. MX2017000154A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2014130365 2014-06-25
PCT/JP2015/068198 WO2015199129A1 (ja) 2014-06-25 2015-06-24 インフルエンザワクチン経鼻接種システム

Publications (1)

Publication Number Publication Date
MX2017000154A true MX2017000154A (es) 2017-05-01

Family

ID=54938207

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000154A MX2017000154A (es) 2014-06-25 2015-06-24 Sistema de rinovacunacion de la vacuna contra la influenza.

Country Status (25)

Country Link
US (1) US11103453B2 (es)
EP (1) EP3162378B1 (es)
JP (1) JP6456379B2 (es)
KR (1) KR102491446B1 (es)
CN (1) CN106573045B (es)
AU (1) AU2015281148B2 (es)
CA (1) CA2951982A1 (es)
DK (1) DK3162378T3 (es)
ES (1) ES2973258T3 (es)
FI (1) FI3162378T3 (es)
HU (1) HUE065638T2 (es)
IL (1) IL249500A0 (es)
LT (1) LT3162378T (es)
MA (1) MA40181A (es)
MX (1) MX2017000154A (es)
MY (1) MY192073A (es)
NZ (1) NZ727360A (es)
PH (1) PH12016502529A1 (es)
PL (1) PL3162378T3 (es)
PT (1) PT3162378T (es)
RU (1) RU2696483C2 (es)
SG (2) SG10201811438XA (es)
SI (1) SI3162378T1 (es)
TW (1) TWI721949B (es)
WO (1) WO2015199129A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12070497B2 (en) * 2018-06-05 2024-08-27 Toko Yakuhin Kogyo Co., Ltd. Hepatitis B vaccine transnasal administration system
JP7288270B2 (ja) * 2018-09-26 2023-06-07 デンカ株式会社 不活化全粒子インフルエンザワクチン及びその調製法
US11759586B1 (en) * 2022-04-13 2023-09-19 Ferrer Medical Innovations, LLC Nasal spray bottle with improved nozzle and system of application

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3669359A (en) 1970-09-18 1972-06-13 Precision Valve Corp Aerosol mechanical break-up nozzle insert
JPH0291553A (ja) 1988-09-29 1990-03-30 Toshiba Corp 産業用ｃｔ装置
JPH0529703Y2 (es) * 1988-12-28 1993-07-29
US5158761A (en) * 1989-04-05 1992-10-27 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
US5215739A (en) * 1989-04-05 1993-06-01 Toko Yakuhin Kogyo Kabushiki Kaisha Spray gel base and spray gel preparation using thereof
JPH0678245B2 (ja) * 1989-07-04 1994-10-05 東興薬品工業株式会社 鼻腔内噴霧投与用インフルエンザワクチンゲル製剤
JP2922935B2 (ja) * 1989-08-11 1999-07-26 東興薬品工業株式会社 粘稠液用鼻孔内噴霧容器の使捨てアダプタ
JPH03114248A (ja) 1990-08-30 1991-05-15 Ibiden Co Ltd 半導体搭載用プリント配線基板の製造方法
IT1249600B (it) 1991-02-21 1995-03-09 Elettro Plastica Spa Erogatore nasale di sostanze farmaceutiche nebulizzate
US5601077A (en) 1991-08-07 1997-02-11 Becton, Dickinson And Company Nasal syringe sprayer with removable dose limiting structure
KR0151476B1 (ko) * 1995-04-29 1998-10-15 배순훈 헤드드럼 조립체 및 그 조립방법
FR2773784B1 (fr) 1998-01-16 2000-03-24 Valois Sa Tete de pulverisation pour un distributeur de produit fluide
ES2214204T3 (es) 1999-10-14 2004-09-16 Becton, Dickinson And Company Dispositivo de administracion nasal que incluye una boquilla de pulverizacion.
BR0309373B1 (pt) 2002-05-09 2012-09-04 dispositivo de dispensação de fluido.
CA2648553C (en) * 2006-04-21 2015-01-27 Toko Yakuhin Kogyo Kabushiki Kaisha Sprayable gel-type skin/mucosa-adhesive preparation and administration system using the preparation
JP5072834B2 (ja) * 2006-04-21 2012-11-14 東興薬品工業株式会社 流体用容器およびこれを用いたエアレス式流体投与システム
US9050433B2 (en) 2007-11-29 2015-06-09 Glaxo Group Limited Dispensing device
ES2588183T3 (es) 2009-03-31 2016-10-31 Japan As Represented By Director-General Of National Institute Of Infectious Diseases Procedimiento para la prevención de la gripe utilizando una vacuna para administración intranasal
FR2951442B1 (fr) 2009-10-20 2012-01-20 Valois Sas Tete de distribution pour dispositif de distribution de produit fluide.
WO2013145789A1 (ja) * 2012-03-30 2013-10-03 株式会社吉野工業所 定量シリンジ型噴出器
JP5917367B2 (ja) * 2012-10-31 2016-05-11 株式会社吉野工業所 蓄圧式シリンジ型空気混合液噴出器
BR112015015523B1 (pt) * 2012-12-28 2023-02-23 Japan As Represented By Director-General Of National Institute Of Infectious Diseases Composição de vacina nasal para influenza

Also Published As

Publication number Publication date
MY192073A (en) 2022-07-25
RU2696483C2 (ru) 2019-08-02
PT3162378T (pt) 2024-03-05
FI3162378T3 (fi) 2024-03-18
EP3162378A4 (en) 2018-01-17
WO2015199129A1 (ja) 2015-12-30
US20170128363A1 (en) 2017-05-11
SG11201610567TA (en) 2017-01-27
DK3162378T3 (da) 2024-03-18
PL3162378T3 (pl) 2024-04-29
PH12016502529B1 (en) 2017-04-10
IL249500A0 (en) 2017-02-28
NZ727360A (en) 2023-05-26
AU2015281148A1 (en) 2017-01-12
EP3162378B1 (en) 2024-01-10
PH12016502529A1 (en) 2017-04-10
AU2015281148B2 (en) 2020-07-30
JPWO2015199129A1 (ja) 2017-05-25
US11103453B2 (en) 2021-08-31
SI3162378T1 (sl) 2024-04-30
KR102491446B1 (ko) 2023-01-20
RU2017101987A3 (es) 2018-09-26
CN106573045B (zh) 2020-10-27
ES2973258T3 (es) 2024-06-19
SG10201811438XA (en) 2019-02-27
TWI721949B (zh) 2021-03-21
MA40181A (fr) 2017-05-03
CA2951982A1 (en) 2015-12-30
KR20170023089A (ko) 2017-03-02
TW201625327A (zh) 2016-07-16
RU2017101987A (ru) 2018-08-02
LT3162378T (lt) 2024-03-12
CN106573045A (zh) 2017-04-19
EP3162378A1 (en) 2017-05-03
HUE065638T2 (hu) 2024-06-28
JP6456379B2 (ja) 2019-01-23

Similar Documents

Publication Publication Date Title
CY1122372T1 (el) Συνθεση ρινικου εμβολιου γριπης
MX2018007627A (es) Vacuna contra el virus del zika.
MX2019006733A (es) Activacion farmaceutica de una senda de señalizacion de di-nucleotido ciclico de mamifero.
MX2022002106A (es) Formulaciones de vacuna de vial unico.
EA201391515A1 (ru) Инактивированная вакцина вируса денге
MX2015007753A (es) Composicion de vacunas para sujetos intactos.
PH12015000376B1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
BR112016026651A2 (pt) evolução de vesículas semelhantes a vírus de alta titulação para aplicações de vacina
PH12016502529A1 (en) Influenza vaccine nasal vaccination system
NZ739260A (en) Inactivated canine influenza vaccines and methods of making and uses thereof
SG10201811190SA (en) Cancer immunotherapy by delivering class ii mhc antigens using a vlp-replicon
BR112014020025A2 (pt) vacinas de subunidade de rotavirus e métodos de produção e uso das mesmas
PH12015502844A1 (en) Mammalian milk osteopontin for enhancing immune responsiveness
DK201370530A (en) Salmonid alphavirus vaccine
MX2017006744A (es) Composiciones adyuvantes y metodos relacionados.
EP3599247A3 (en) Recombinant hemagglutinin protein of influenza virus and vaccine containing the same
BR112016025977A2 (pt) composições, métodos e utilizações para formulações de papilomavirus humano estábulo estável
BR112017002206A2 (pt) peptídeo derivado de koc1 e vacina incluindo o mesmo
EA202091745A1 (ru) Вакцинация дендритными клетками после химиотерапии
PH12017500928B1 (en) A rabies composition comprising pika adjuvant
BR112022002082A2 (pt) Formulações de vacina contra o chikungunya
BR112017007102A2 (pt) uso de um medicamento no tratamento de patologias da córnea, composição oftálmica para uso de um medicamento no tratamento de doenças da córnea e método para preparar a composição oftálmica
EA201892488A1 (ru) Комбинации лечебных вакцин против впч
MX2014003939A (es) Sistema farmaceutico para la administracion oral de sustancias terapeuticas sensibles.
MX2014008984A (es) Proceso de obtencion y composicion farmaceutica de fenofibrato capsulas como agente regulador de lipidos para su administracion oral.